OA00945A - Process for the preparation of sufapyrimidines. - Google Patents

Process for the preparation of sufapyrimidines.

Info

Publication number
OA00945A
OA00945A OA51040A OA51040A OA00945A OA 00945 A OA00945 A OA 00945A OA 51040 A OA51040 A OA 51040A OA 51040 A OA51040 A OA 51040A OA 00945 A OA00945 A OA 00945A
Authority
OA
OAPI
Prior art keywords
sufapyrimidines
preparation
Prior art date
Application number
OA51040A
Other languages
French (fr)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of OA00945A publication Critical patent/OA00945A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines
OA51040A 1961-11-09 1964-12-26 Process for the preparation of sufapyrimidines. OA00945A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1299161A CH396916A (en) 1961-11-09 1961-11-09 Process for the preparation of new sulfonamides of the pyrimidine series

Publications (1)

Publication Number Publication Date
OA00945A true OA00945A (en) 1968-03-22

Family

ID=4388304

Family Applications (1)

Application Number Title Priority Date Filing Date
OA51040A OA00945A (en) 1961-11-09 1964-12-26 Process for the preparation of sufapyrimidines.

Country Status (8)

Country Link
BE (1) BE624330A (en)
BR (1) BR6244435D0 (en)
CH (1) CH396916A (en)
DE (1) DE1192652B (en)
ES (1) ES282282A1 (en)
GB (1) GB957257A (en)
NL (1) NL285045A (en)
OA (1) OA00945A (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL121729C (en) * 1959-08-20

Also Published As

Publication number Publication date
BE624330A (en)
ES282282A1 (en) 1963-05-01
NL285045A (en)
BR6244435D0 (en) 1973-07-19
GB957257A (en) 1964-05-06
CH396916A (en) 1965-08-15
DE1192652B (en) 1965-05-13

Similar Documents

Publication Publication Date Title
OA03371A (en) Process for the preparation of anteric drugs.
OA00942A (en) Process for the preparation of new ethers.
FR1316269A (en) Process for the preparation of poly
BE625529A (en) Process for the preparation of metal 8-hydroxyquinolinates.
OA00944A (en) Process for the preparation of sulfapyrimidines.
OA01072A (en) Process for the preparation of α-pyrrolidino-valerophenones.
FR1320500A (en) Process for the preparation of nitriles
FR93252E (en) Process for the preparation of haloalkyl-thiazols.
FR1341774A (en) Process for the preparation of sulfapyrimidines
OA00945A (en) Process for the preparation of sufapyrimidines.
FR1302193A (en) Process for the preparation of 1.3-dialkyl-cyclobutenolones
FR1300297A (en) Process for the preparation of methyl-3-chromone
FR1337997A (en) Process for the preparation of 7-aminopteridines
FR1294974A (en) Process for the preparation of gallium-alkyls
FR1310522A (en) Process for the preparation of 2-cyano-3-oxo-steroids
FR1325344A (en) Process for the preparation of sulfapyrimidines
BE618802A (en) Process for the preparation of triaminotriazoles
OA00405A (en) Process for the preparation of novel banzenesulfonyl-semicarbazides.
BE624085A (en) Process for the preparation of 2-hydroxycyclododecanone.
FR1312034A (en) Process for the preparation of substituted tetrahydro-pyranes
OA01374A (en) Process for the preparation of benzene-sulfonyl-semicarbazides.
OA00957A (en) Process for the preparation of sulfapyrimidines.
BE605328A (en) Process for the preparation of sulfapyrimidines.
FR1337745A (en) Process for the preparation of new sulfapyrimidines
CH399444A (en) Process for the preparation of 17B-acyloxy-A-nor-B-homo-5,10 -estranes